Woodline Partners’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.2M | Hold |
|
|||||
|
2025
Q2 | $1.8M | Sell |
|
|||||
|
2025
Q1 | $4.71M | Sell |
|
|||||
|
2024
Q4 | $8.13M | Sell |
|
|||||
|
2024
Q3 | $46.5M | Buy |
|
|||||
|
2024
Q2 | $8.1M | Buy |
|
|||||
|
2024
Q1 | $6.02M | Sell |
|
|||||
|
2023
Q4 | $10M | Buy |
|
|||||
|
2023
Q3 | $7.67M | Buy |
|
|||||
|
2023
Q2 | $9.65M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $960K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.56M | Buy |
|